Long‐term cost‐effectiveness analysis of tirzepatide versus semaglutide 1.0 mg for the management of type 2 diabetes in the US
Valentine WJ, Hoog M, Mody R, et al.
Diabetes Obes Metab. Pub. online 18 Jan 2023.
Leggi
Valentine WJ, Hoog M, Mody R, et al.
Diabetes Obes Metab. Pub. online 18 Jan 2023.
Leggi
Ling S, Zaccardi F, Issa E, et al.
Diabetologia. Pub. online 24 Jan 2023.
Leggi
Svehlikova E, Ashcroft NL, Gatschelhofer C, et al.
Diabetes Care. 2023;dc221054.
Leggi
de Vries SAG, Verheugt CL, Mul D, et al.
Diabetologia. Pub. online 26 Jan 2023.
Leggi
Hinton W, Ansari AS, Whyte MB, et al.
Diabetes Obes Metab. 2023;25(2):501-515.
Leggi
Carrera P, Marzinotto I, Bonfanti R, et al.
Diabetologia. Pub. online 24 Jan 2023.
Leggi
Yoo TK, Lee MY, Kim SH, et al.
NMCD. Pub. Online 24 Jan 2023.
Leggi
Fawzy AM, Rivera-Caravaca JM, Underhill P, et al.
Diabetes Obes Metab. 2023;25(2):602-610.
Leggi
Lund LC, Hjorslev Jensen P, Pottegård A, et al.
Diabetes Obes Metab. Pub. Online 22 Jan 2023.
Leggi
Khan MS, Shahid I, Anker SD, et al.
J Am Coll Cardiol. 2023;81(3):270-82.
Leggi